20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T77510 | SARS-CoV-2-IN-46 | SARS-CoV | |
SARS-CoV-2-IN-46 is a SARS-CoV-2 inhibitor. | |||
T77516 | SARS-CoV-2-IN-39 | Antiviral , SARS-CoV | |
SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1. | |||
T77652 | SARS-CoV-2 3CLpro-IN-20 | Antiviral , SARS-CoV | |
SARS-CoV-2 3CLpro-IN-20 is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.43 μM,).SARS-CoV-2 3CLpro-IN-20 has potential antiviral activity. | |||
T60538 | SARS-CoV-2-IN-14 | 3',5-Dichlorosalicylanilide | SARS-CoV |
SARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 μM), which is an analogue of niclosamide. SARS-CoV-2-IN-14 was more stable than niclosamide in the determination of human plasma and liver S9 enzym... | |||
T9458 | PF-00835231 | SARS-CoV | |
PF-00835231 is a CoV-2 cysteine 3C-like protease (3CLpro) inhibitor, with IC50s of 0.27 nM and 4 nM for SARS CoV-2 and SARS CoV-1 3CLpro, respectively.PF-00835231 is the active compound of the first anti-3CLpro regimen i... | |||
T40207 | SARS-CoV-2-IN-7 | ||
SARS-CoV-2-IN-7 demonstrates potent inhibition of viral replication in SARS-CoV-2-infected Vero E6 cells with an IC50 value of 844 nM. | |||
T38942 | SARS-CoV-2-IN-9 | ||
SARS-CoV-2-IN-9 is an inhibitor binding to subsites S1 and S2 in SARS-CoV-2 main protease. | |||
T40340 | SARS-CoV-2-IN-10 | ||
SARS-CoV-2-IN-10 is a powerful and non-toxic inhibitor of SARS-CoV-2 3CL protease, with IC50 and EC50 values of 0.13 nM and 1.03 nM, respectively. The SARS-CoV-2 3C-like protease (3CLpro) is a critical enzyme for viral r... | |||
T40341 | SARS-CoV-2-IN-11 | ||
SARS-CoV-2-IN-11 is a highly potent and non-toxic inhibitor of the 3C-like protease (3CLpro) of SARS-CoV-2, demonstrating IC50 and EC50 values of 0.17 nM and 1.45 nM, respectively. This compound targets the essential vir... | |||
T12838 | SARS-CoV-IN-2 | Others | |
SARS-CoV-IN-2 is an effective SARS-CoV replication inhibitor | |||
T36654 | Anti-SARS-CoV-2 Spike mAb (CR3022) | Anti-SARS-CoV-2 Spike mAb (CR3022) | |
Anti-SARS-CoV-2 Spike mAb (CR3022) is a human monoclonal IgG1 antibody derived from CHO cells. It specifically targets the S1 domain of the Spike protein in both SARS-CoV and SARS-CoV-2. | |||
T12836 | SARS-CoV-2-IN-1 | Others | |
SARS-CoV-2-IN-1 is a potent inhibitor of Mpro(SARS-CoV-2 Mpro, SARS-CoV Mpro and MERS-CoV Mpro with IC50s of 0.67, 0.90 and 0.58 μM, respectively). | |||
T60919 | SARS-CoV-2-IN-13 | SARS-CoV | |
SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when ad... | |||
T63098 | SARS-CoV-2 Mpro-IN-2 | ||
SARS-CoV-2 MPro-IN-2 is a selective, low cytotoxic, non-covalent Mpro inhibitor with an IC50 value of 0.40 μM. SARS-CoV-2 Mpro-IN-2 showed good anti-SARS-CoV-2 effect with EC50 value of 1.1 μM. SARS-CoV-2 Mpro-IN-2 can b... | |||
T79659 | SARS-CoV-2 3CLpro-IN-16 | SARS-CoV | |
SARS-CoV-2 3CLpro-IN-16 is a covalent SARS-CoV-2 3CLpro inhibitor that inhibits 3CLpro activity and achieves its inhibitory effect by forming a covalent bond with Cys145. | |||
T1817 | GNF-2 | GNF2 | SARS-CoV , Bcr-Abl |
GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl. | |||
T7991 | 2-Hydroxycinnamic acid | Others , SARS-CoV , HIV Protease | |
2-Hydroxycinnamic acid is a natural product isolated from Angraecum fragrans, has photooxidant activity. | |||
T12502 | PLpro inhibitor | SARS-CoV | |
PLpro inhibitor is a potent papain-like protease (PLpro) inhibitor(IC50 of 2.6 uM) | |||
T2486 | IOWH-032 | IOWH032,IOWH 032 | CFTR , Autophagy |
IOWH-032 (IOWH032) , a synthetic CFTR inhibitor, has been investigated for the treatment of cholera, diarrhea, and secretory diarrhea. | |||
T9287 | Hydroxychloroquine | 2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol | SARS-CoV , TLR , Parasite , Autophagy |
Hydroxychloroquine (2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol) (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It i... |